Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis

[1]  A. Uzawa,et al.  Serum high mobility group box 1 is upregulated in myasthenia gravis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  A. Uzawa,et al.  Serum cytokine and chemokine profiles in patients with myasthenia gravis , 2014, Clinical and experimental immunology.

[3]  J. Vencovský,et al.  The Role of Resistin in Inflammatory Myopathies , 2013, Current Rheumatology Reports.

[4]  S. Gamal,et al.  Resistin in inflammatory and degenerative rheumatologic diseases , 2013, Zeitschrift für Rheumatologie.

[5]  M. Mori,et al.  CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  F. Shi,et al.  Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis , 2012, Neuroscience Bulletin.

[7]  A. Vincent,et al.  Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China , 2011, Journal of the Neurological Sciences.

[8]  H. Jones,et al.  Ocular myasthenia gravis in a senior population: Diagnosis, therapy, and prognosis , 2010, Muscle & nerve.

[9]  V. Hombach,et al.  Resistin: a newly identified chemokine for human CD4-positive lymphocytes. , 2010, Cardiovascular research.

[10]  U. Dahlgren,et al.  Salivary resistin reflects local inflammation in Sjögren's syndrome. , 2008, The Journal of rheumatology.

[11]  M. Bokarewa,et al.  Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. , 2008, Rheumatology.

[12]  A. Vincent,et al.  IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis† , 2008, Brain : a journal of neurology.

[13]  M. Bokarewa,et al.  Role of resistin as a marker of inflammation in systemic lupus erythematosus , 2008, Arthritis research & therapy.

[14]  S. Sébillaud,et al.  Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis , 2008, Arthritis research & therapy.

[15]  M. Haluzík,et al.  Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression. , 2008, Neoplasma.

[16]  F. Seibold,et al.  Resistin is an inflammatory marker of inflammatory bowel disease in humans , 2007, European journal of gastroenterology & hepatology.

[17]  E. Kouroumalis,et al.  The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease , 2007, European journal of gastroenterology & hepatology.

[18]  W. Oertel,et al.  Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis , 2007, European journal of immunology.

[19]  U. Müller-Ladner,et al.  Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum , 2006, Annals of the rheumatic diseases.

[20]  U. Smith,et al.  Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes , 2006, PloS one.

[21]  J. Małyszko,et al.  Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. , 2006, Transplantation proceedings.

[22]  K. Migita,et al.  The serum levels of resistin in rheumatoid arthritis patients. , 2006, Clinical and experimental rheumatology.

[23]  F. Di Nicuolo,et al.  Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. , 2006, The Journal of endocrinology.

[24]  U. Smith,et al.  Resistin, an Adipokine with Potent Proinflammatory Properties1 , 2005, The Journal of Immunology.

[25]  U. Müller-Ladner,et al.  Adipocytokines in synovial fluid. , 2003, JAMA.

[26]  Joanna D. Holbrook,et al.  Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .

[27]  B. Scallon,et al.  Anti-TNF-α Antibodies Suppress the Development of Experimental Autoimmune Myasthenia Gravis , 2002 .

[28]  P. Christadoss,et al.  Resistance to Experimental Autoimmune Myasthenia Gravis in IL-6-Deficient Mice Is Associated with Reduced Germinal Center Formation and C3 Production1 , 2002, The Journal of Immunology.

[29]  M. Lazar,et al.  The hormone resistin links obesity to diabetes , 2001, Nature.

[30]  R. Barohn,et al.  Myasthenia gravis , 2000, Neurology.

[31]  P. Lipsky,et al.  Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-alpha and interleukin 1. , 1987, Journal of immunology.

[32]  A. Vincent,et al.  Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. , 1985, Journal of neurology, neurosurgery, and psychiatry.